Red cell distribution width: A surrogate biomarker to predict tumor burden in carcinoma gallbladder

Aim: To assess the role of red cell distribution width as a marker to predict tumor burden in gallbladder cancer (GBC). Methods: One hundred and twenty-eight patients with newly diagnosed GBC were included in the study. Peripheral blood samples were obtained, and red cell distribution width (RDW) wa...

Full description

Bibliographic Details
Main Authors: Amit Gupta, Sweety Gupta, Ashish Gupta, Arvind Gupta, Bela Goyal, Saumya Agrawal, L Manoj Joshua, Utkarsh Kumar, Bina Ravi, Ravi Kant
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Nigerian Journal of Surgery
Subjects:
Online Access:http://www.nigerianjsurg.com/article.asp?issn=1117-6806;year=2019;volume=25;issue=2;spage=198;epage=202;aulast=
_version_ 1819035769399934976
author Amit Gupta
Sweety Gupta
Ashish Gupta
Arvind Gupta
Bela Goyal
Saumya Agrawal
L Manoj Joshua
Utkarsh Kumar
Bina Ravi
Ravi Kant
author_facet Amit Gupta
Sweety Gupta
Ashish Gupta
Arvind Gupta
Bela Goyal
Saumya Agrawal
L Manoj Joshua
Utkarsh Kumar
Bina Ravi
Ravi Kant
author_sort Amit Gupta
collection DOAJ
description Aim: To assess the role of red cell distribution width as a marker to predict tumor burden in gallbladder cancer (GBC). Methods: One hundred and twenty-eight patients with newly diagnosed GBC were included in the study. Peripheral blood samples were obtained, and red cell distribution width (RDW) was assessed. Tumor markers and other biochemical parameters were also recorded. Statistical Analysis: Quantitative variables were summarized using mean and standard deviation or median and interquartile range based on the normality of the distribution. The association of RDW with stage of tumor was analyzed using Chi-square test. All statistical tests were interpreted for significance using a cutoff value of P < 0.05. Results: RDW showed a positive correlation with total bilirubin, total leukocyte count, and erythrocyte sedimentation rate (P < 0.002), but not with platelet count (P < 0.643). RDW showed a significant correlation with tumor markers CA 19-9 (P < 0.003), carcinoembryonic antigen (P < 0.003), and CA 125 (P < 0.002). In Stage IVB, there were significantly more patients with high RDW (78%) than normal RDW (21.8%). However, the results were not statistically significant (P < 0.073). Conclusion: In the present study, we have utilized RDW for correlation with tumor markers in carcinoma gallbladder and as a predictor of stage. We demonstrated higher levels of RDW with advanced stages of GBC. Overall, the study suggested that RDW may be utilized as a surrogate biomarker to predict tumor burden and disease in patients with GBC.
first_indexed 2024-12-21T07:54:53Z
format Article
id doaj.art-4eae5a740d0c45a68d5b71b1c61bfce5
institution Directory Open Access Journal
issn 1117-6806
language English
last_indexed 2024-12-21T07:54:53Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Nigerian Journal of Surgery
spelling doaj.art-4eae5a740d0c45a68d5b71b1c61bfce52022-12-21T19:10:59ZengWolters Kluwer Medknow PublicationsNigerian Journal of Surgery1117-68062019-01-0125219820210.4103/njs.NJS_22_19Red cell distribution width: A surrogate biomarker to predict tumor burden in carcinoma gallbladderAmit GuptaSweety GuptaAshish GuptaArvind GuptaBela GoyalSaumya AgrawalL Manoj JoshuaUtkarsh KumarBina RaviRavi KantAim: To assess the role of red cell distribution width as a marker to predict tumor burden in gallbladder cancer (GBC). Methods: One hundred and twenty-eight patients with newly diagnosed GBC were included in the study. Peripheral blood samples were obtained, and red cell distribution width (RDW) was assessed. Tumor markers and other biochemical parameters were also recorded. Statistical Analysis: Quantitative variables were summarized using mean and standard deviation or median and interquartile range based on the normality of the distribution. The association of RDW with stage of tumor was analyzed using Chi-square test. All statistical tests were interpreted for significance using a cutoff value of P < 0.05. Results: RDW showed a positive correlation with total bilirubin, total leukocyte count, and erythrocyte sedimentation rate (P < 0.002), but not with platelet count (P < 0.643). RDW showed a significant correlation with tumor markers CA 19-9 (P < 0.003), carcinoembryonic antigen (P < 0.003), and CA 125 (P < 0.002). In Stage IVB, there were significantly more patients with high RDW (78%) than normal RDW (21.8%). However, the results were not statistically significant (P < 0.073). Conclusion: In the present study, we have utilized RDW for correlation with tumor markers in carcinoma gallbladder and as a predictor of stage. We demonstrated higher levels of RDW with advanced stages of GBC. Overall, the study suggested that RDW may be utilized as a surrogate biomarker to predict tumor burden and disease in patients with GBC.http://www.nigerianjsurg.com/article.asp?issn=1117-6806;year=2019;volume=25;issue=2;spage=198;epage=202;aulast=Gallbladderred cell widthtumor markers
spellingShingle Amit Gupta
Sweety Gupta
Ashish Gupta
Arvind Gupta
Bela Goyal
Saumya Agrawal
L Manoj Joshua
Utkarsh Kumar
Bina Ravi
Ravi Kant
Red cell distribution width: A surrogate biomarker to predict tumor burden in carcinoma gallbladder
Nigerian Journal of Surgery
Gallbladder
red cell width
tumor markers
title Red cell distribution width: A surrogate biomarker to predict tumor burden in carcinoma gallbladder
title_full Red cell distribution width: A surrogate biomarker to predict tumor burden in carcinoma gallbladder
title_fullStr Red cell distribution width: A surrogate biomarker to predict tumor burden in carcinoma gallbladder
title_full_unstemmed Red cell distribution width: A surrogate biomarker to predict tumor burden in carcinoma gallbladder
title_short Red cell distribution width: A surrogate biomarker to predict tumor burden in carcinoma gallbladder
title_sort red cell distribution width a surrogate biomarker to predict tumor burden in carcinoma gallbladder
topic Gallbladder
red cell width
tumor markers
url http://www.nigerianjsurg.com/article.asp?issn=1117-6806;year=2019;volume=25;issue=2;spage=198;epage=202;aulast=
work_keys_str_mv AT amitgupta redcelldistributionwidthasurrogatebiomarkertopredicttumorburdenincarcinomagallbladder
AT sweetygupta redcelldistributionwidthasurrogatebiomarkertopredicttumorburdenincarcinomagallbladder
AT ashishgupta redcelldistributionwidthasurrogatebiomarkertopredicttumorburdenincarcinomagallbladder
AT arvindgupta redcelldistributionwidthasurrogatebiomarkertopredicttumorburdenincarcinomagallbladder
AT belagoyal redcelldistributionwidthasurrogatebiomarkertopredicttumorburdenincarcinomagallbladder
AT saumyaagrawal redcelldistributionwidthasurrogatebiomarkertopredicttumorburdenincarcinomagallbladder
AT lmanojjoshua redcelldistributionwidthasurrogatebiomarkertopredicttumorburdenincarcinomagallbladder
AT utkarshkumar redcelldistributionwidthasurrogatebiomarkertopredicttumorburdenincarcinomagallbladder
AT binaravi redcelldistributionwidthasurrogatebiomarkertopredicttumorburdenincarcinomagallbladder
AT ravikant redcelldistributionwidthasurrogatebiomarkertopredicttumorburdenincarcinomagallbladder